XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 54 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $7,387,000 | -12.9% | 1,815,091 | -3.5% | 0.06% | -11.1% |
| Q1 2021 | $8,482,000 | -13.0% | 1,880,722 | -5.1% | 0.06% | -17.1% |
| Q4 2020 | $9,751,000 | -20.8% | 1,981,909 | -4.5% | 0.08% | -35.0% |
| Q3 2020 | $12,307,000 | +104.5% | 2,075,387 | -8.3% | 0.12% | +88.7% |
| Q2 2020 | $6,019,000 | +31.8% | 2,262,608 | -3.4% | 0.06% | +3.3% |
| Q1 2020 | $4,567,000 | -66.4% | 2,341,902 | +21.4% | 0.06% | -50.4% |
| Q4 2019 | $13,595,000 | -16.5% | 1,928,308 | +16.4% | 0.12% | -25.3% |
| Q3 2019 | $16,283,000 | +1.1% | 1,656,422 | +17.7% | 0.16% | +4.5% |
| Q2 2019 | $16,105,000 | +14.6% | 1,407,786 | +0.6% | 0.16% | +17.4% |
| Q1 2019 | $14,053,000 | +26.6% | 1,399,711 | +114.4% | 0.13% | +13.8% |
| Q4 2018 | $11,097,000 | 0.0% | 652,748 | +3.4% | 0.12% | +24.7% |
| Q3 2018 | $11,097,000 | -1.8% | 631,236 | +6.1% | 0.09% | -10.6% |
| Q2 2018 | $11,297,000 | – | 595,202 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |